The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Executive Research: Impact of Incorrect Forecasts on New Product Launches
Webinar On Demand
In today’s drug manufacturing environment, demand forecasts provide critical input that ultimately affects pharmaceutical companies’ decision-making processes. Pharmaceutical companies utilize drug forecasts to design clinical programs, position sales force resources, allocate geographic resource distribution, and obtain company or licensing assets. However, achieving accurate forecasts is extremely challenging, especially for new drug launches.
ORC International recently completed extensive interviews with 50 pharma executives, who consistently utilize launch forecasts to predict manufacturing planning and volume. Join this webinar as we discuss the results of this study, including forecasting processes, key issues that arise from inaccurate forecasts, and how forecasting needs will change over the next few years due to evolving organizational needs.
Authors:
Susan Sebelsky, Director, ORC International
Jim Miller, MBA President, PharmSource,
Joe Principe Vice President, Strategic Partnerships, Patheon